Genotropin (somatropin)
ApprovedCompleted 0 watching 0 views this week🔥 Hot
84
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Short Stature Born Small for Gestational Age (SGA)
Conditions
Short Stature Born Small for Gestational Age (SGA)
Trial Timeline
Oct 1, 2002 → Aug 1, 2015
NCT ID
NCT01859949About Genotropin (somatropin)
Genotropin (somatropin) is a approved stage product being developed by Pfizer for Short Stature Born Small for Gestational Age (SGA). The current trial status is completed. This product is registered under clinical trial identifier NCT01859949. Target conditions include Short Stature Born Small for Gestational Age (SGA).
Hype Score Breakdown
Clinical
30
Activity
20
Company
9
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01859949 | Approved | Completed |
Competing Products
20 competing products in Short Stature Born Small for Gestational Age (SGA)
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| somatropin + leuprorelin | Eli Lilly | Phase 3 | 77 |
| Growth Hormone | Eli Lilly | Approved | 85 |
| Pancreatic Enzyme | AbbVie | Phase 2 | 52 |
| Aromatase Inhibitor + Growth Hormone + Aromatase Inhibitor and Growth Hormone | AstraZeneca | Phase 3 | 77 |
| Oral, live, pentavalent rotavirus vaccine; RotaTeq(R) | Merck | Phase 1 | 33 |
| Saizen® + Saizen® | Merck | Phase 3 | 77 |
| r-metHuLeptin | Amgen | Phase 1 | 32 |
| Somapacitan + Norditropin® | Novo Nordisk | Phase 2 | 51 |
| Somatotropin growth hormone recombinant human | Pfizer | Approved | 84 |
| Genotropin + Genotropin | Pfizer | Phase 3 | 76 |
| GH treatment (Genotropin) + 1 year treatment with placebo followed by optional 3 years of GH treatment | Pfizer | Approved | 84 |
| Genotropin | Pfizer | Phase 2/3 | 64 |
| glepaglutide | Zealand Pharma | Phase 3 | 74 |
| Glepaglutide | Zealand Pharma | Phase 3 | 74 |
| ZP1848 | Zealand Pharma | Phase 2 | 49 |
| glepaglutide + Placebo | Zealand Pharma | Phase 3 | 74 |
| Glepaglutide | Zealand Pharma | Phase 3 | 74 |
| Glepaglutide 10 mg | Zealand Pharma | Phase 3 | 74 |
| Glepaglutide | Zealand Pharma | Phase 3 | 74 |
| Nutropin [Somatropin (rDNA origin) for injection] | Ipsen | Approved | 82 |